Armitage, J. (2008). Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia.
Citación estilo ChicagoArmitage, J. Commentary on NICE Technology Appraisal Guidance on Ezetimibe for the Treatment of Primary (heterozygous-familial and Non-familial) Hypercholesterolaemia. 2008.
Cita MLAArmitage, J. Commentary on NICE Technology Appraisal Guidance on Ezetimibe for the Treatment of Primary (heterozygous-familial and Non-familial) Hypercholesterolaemia. 2008.
Warning: These citations may not always be 100% accurate.